(Press-News.org) April 25, 2015, Vienna , Austria: Phase 3 results presented today at The International Liver Congress™ 2015 show that a combination of daclatasvir (DCV), sofosbuvir (SOF) and ribavirin (RBV) for 12 weeks was effective and well tolerated amongst patients with hepatitis C virus (HCV) infection with advanced cirrhosis and post-transplant recurrence. Sustained virologic response rates at 12 weeks (SVR12) were >90% in patients with Child-Pugh class A or B cirrhosis but lower in Child-Pugh class C. SVR12 was achieved by 94% of liver transplant recipients with HCV recurrence.
ALLY-1 is an open-label study, including treatment-naive or -experienced adults with HCV infection of any genotype.
The most common adverse events (AEs) were headache, fatigue, anaemia, diarrhoea and nausea. There were no treatment-related serious AEs. One post-transplant patient discontinued all therapy after 31 days due to headache but achieved SVR12.
INFORMATION:
About The International Liver Congress™
This annual congress is the biggest event in the EASL calendar, attracting scientific and medical experts from around the world to learn about the latest in liver research. Specialists share research studies and findings, and discuss the hottest topics related to liver disease. This year, the congress is expected to attract approximately 10,000 delegates from all corners of the globe. 2015 is a very special year for EASL and the hepatology community as they will celebrate the 50th annual meeting. The International Liver Congress™ takes place from April 22-26, 2015, Vienna, Austria.
About EASL
Since EASL's foundation in 1966, this not-for-profit organisation has grown to over 4,000 members from more than 100 countries around the world. EASL is the leading liver association in Europe, it attracts the foremost hepatology experts and has an impressive track record in promoting research in liver disease, supporting wider education and promoting changes in European liver policy.
Contact
For more information, please contact the ILC Press Office at:
ilc.press@easloffice.eu or
+44 (0)20 3580 5444
Late Breakers: Hall D
Presentation time: 17:45 - 18:00
Presenter: Fred Poordad (United States)
Abstract LO8: DACLATASVIR, SOFOSBUVIR, AND RIBAVIRIN COMBINATION FOR HCV PATIENTS WITH ADVANCED CIRRHOSIS OR POSTTRANSPLANT RECURRENCE: PHASE 3 ALLY-1 STUDY
DACLATASVIR, SOFOSBUVIR, AND RIBAVIRIN COMBINATION FOR HCV PATIENTS WITH ADVANCED CIRRHOSIS OR POSTTRANSPLANT RECURRENCE: PHASE 3 ALLY-1 STUDY
Fred Poordad* 1, Eugene R. Schiff2, John M. Vierling3, Charles Landis4, Robert J. Fontana5, Rong Yang6, Fiona McPhee7, Eric Hughes6, Stephanie Noviello6, Eugene S. Swenson7
1Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX, 2Schiff Center for Liver Diseases, University of Miami Miller School of Medicine, Miami, FL, 3Baylor College of Medicine, Houston, TX, 4University of Washington School of Medicine, Seattle, WA, 5University of Michigan Medical Center, Ann Arbor, MI, 6Bristol-Myers Squibb, Princeton, NJ, 7Bristol-Myers Squibb, Wallingford, CT, United States
Introduction: The pangenotypic combination of daclatasvir (DCV) and sofosbuvir (SOF) achieves high rates of SVR in patients with chronic HCV infection. DCV+SOF has favorable safety and drug interaction profiles and a high resistance barrier. These attributes support the ALLY-1 study of DCV+SOF with ribavirin (RBV) in patients with advanced cirrhosis or post-liver transplant HCV recurrence, who have a high unmet therapeutic need.
Material and Methods: This open-label study enrolled treatment-naive or experienced adults with HCV infection of any genotype (GT) in 2 cohorts: (1) advanced cirrhosis, (2) post-liver transplant recurrence. Patients received 12 weeks of treatment with once-daily DCV 60mg + once-daily SOF 400mg and RBV (initially 600mg/d, adjusted for hemoglobin and creatinine clearance). In the cirrhosis cohort, patients transplanted during treatment could receive 12 weeks of extended treatment immediately posttransplant, regardless of treatment duration before transplant. The primary endpoint was HCV RNA 90% in patients with Child-Pugh class A or B cirrhosis but lower in Child-Pugh class C. SVR12 was achieved by 94% of liver transplant recipients with HCV.
Disclosure of Interest: F. Poordad: Grant: Conflict with: BMS, Gilead, Abbvie, Janssen, Salix, Idenix, Theravance, Achillion, Consultant: Conflict with: BMS, Gilead, Abbvie, Janssen, Salix, E. Schiff: Grant: Conflict with: Abbvie, BMS, Gilead, Merck, Orasure Technologies, Roche Molecular, Janssen Pharma, Discovery Life Sciences, Beckman Coulter, Siemens, MedMira, Conatus, Consultant: Conflict with: BMS, Gilead, Merck, Janssen Pharma, Salix, Pfizer, Arrowhead, Acorda, J. Vierling: Grant: Conflict with: BMS, Abbvie, Consultant: Conflict with: Abbvie, Gilead, Intercept, Janssen, Novartis, Roche, Merck, Sundise, C. Landis: Grant: Conflict with: Gilead, Abbvie, BMS, Janssen, R. Fontana: Grant: Conflict with: Gilead, Janssen, and BMS, Consultant: Conflict with: Chronic Liver Disease Foundation , R. Yang: Stockholder: Conflict with: BMS, Employee: Conflict with: BMS, F. McPhee: Employee: Conflict with: BMS, E. Hughes: Employee: Conflict with: BMS, S. Noviello: Employee: Conflict with: BMS, E. Swenson: Employee: Conflict with: BMS
PROVIDENCE, R.I. [Brown University] -- In 2009, the year she won the Nobel Prize for economics, Elinor Ostrom proposed a framework to integrate both the institutional and ecological dimensions of a pervasive global challenge: achieving sustainability. Now researchers have put Ostrom's social-ecological systems theory into practice in the Mexican state of Baja California Sur. The result is a map of regional strengths and weaknesses that can help guide fishers, conservationists, and other decision makers as they consider steps to preserve the peninsula's vital coastal marine ...
Reported emissions of a group of potent greenhouse gases from developed countries are shown to be largely accurate, but for the wrong reasons, according to new findings from an international team, led by researchers at the University of Bristol,UK.
Until now, there has been little verification of the reported emissions of hydrofluorocarbons (HFCs), gases that are used in refrigerators and air conditioners, resulting in an unexplained gap between the amount reported, and the rise in concentrations seen in the atmosphere. This new study shows that this gap can be almost ...
The ocean has been sucking up heat-trapping carbon dioxide (CO2) building up in our atmosphere--with a little help from tiny plankton. Like plants on land, these plankton convert CO2 into organic carbon via photosynthesis. But unlike land plants that are held fast to terra firma, plankton can sink into the deep ocean, carrying carbon with them. Along the way they decompose when bacteria convert their remains back into CO2.
It's called the "biological pump," and if it operated 100 percent efficiently, nearly every atom of carbon drawn into the ocean would be converted ...
A Simon Fraser University researcher has uncovered what may be the first quantified evidence demonstrating a relationship between upright locomotion and spinal health.
Scientists have long pondered whether there is a link between walking upright and back problems, since people have more back pain than other primates such as chimpanzees, with whom we share 98 per cent of our DNA.
Kimberly Plomp, a post-doctoral fellow and biological anthropologist, spent the past seven years studying ancient bones for the telltale signs of disease and injury that give archaeologists ...
Beginning in the 1880s, coastal dunes in the United States were planted with European beachgrass (Ammophila arenaria) in an attempt to hold the sand in place and prevent it from migrating. The grass did the job it was brought in to do. As it trapped sand in its deep roots, the dunes at the beachfront grew higher and steeper and less sand moved inland. But, like many attempts to control nature, this one had unintended consequences.
Although dunes may look barren, they are actually reservoirs of biodiversity. "If you're a plant lover, the sand dunes are just spectacular," ...
(Millbrook, NY) The month of May brings many things, among them Mother's Day, tulips, and Lyme Disease Awareness campaigns. But according to Dr. Richard S. Ostfeld, a disease ecologist at the Cary Institute of Ecosystem Studies in Millbrook, NY, if we want to get a leg up on tick-borne illness we need to become vigilant earlier in the season.
In New York State, the blacklegged ticks that carry Lyme disease and other pathogens are already active in late April. Ostfeld explains: "For more than two decades, we've been monitoring tick activity in the Hudson Valley region ...
KNOXVILLE--The monk parakeets that have invaded Europe and North America over the last 40-50 years fortifying their massive communal nests atop utility poles in many urban areas appear to have originated from the same small area in South America, according to a new study.
Considered one of the best speaking parrots, thousands of these bright green birds have been imported for the pet trade, and feral populations began appearing in the United States in the 1960s and in Europe in the 1980s. And yet, these two independent invasions--in the United States and in Europe--appear ...
(SACRAMENTO, Calif.) -- UC Davis investigators have settled a long-standing controversy surrounding the molecular basis of an inherited disorder that historically affected Ashkenazi Jews from Eastern Europe but now also arises in other populations of Semitic descent, particularly families from Saudi Arabia.
Through a series of elegant experiments, the researchers uncovered the biochemical underpinnings of Canavan disease, a type of leukodystrophy that is an incurable and progressively fatal neurological condition. The UC Davis team identified an abnormally high buildup ...
COLUMBUS, Ohio - A national survey released today by The Ohio State University Wexner Medical Center shows that most women don't know the risks or symptoms females face when it comes to having a stroke.
The survey of 1,000 women released in time for Stroke Awareness Month in May found that only 11 percent of women could correctly identify pregnancy, lupus, migraine headaches and oral contraception or hormone replacement therapy as female-specific stroke risks.
The survey also found that only 10 percent were aware that hiccups combined with atypical chest pain are among ...
Astronomers using the National Science Foundation's Very Large Array (VLA) have found a long-sought "missing link" between supernova explosions that generate gamma-ray bursts (GRBs) and those that don't. The scientists found that a stellar explosion seen in 2012 has many characteristics expected of one that generates a powerful burst of gamma rays, yet no such burst occurred.
"This is a striking result that provides a key insight about the mechanism underlying these explosions," said Sayan Chakraborti, of the Harvard-Smithsonian Center for Astrophysics (CfA). "This object ...
